| MultiLoc: prediction of protein subcellular localization using N-terminal targeting sequences, sequence motifs and amino acid composition A Höglund, P Dönnes, T Blum, HW Adolph, O Kohlbacher Bioinformatics 22 (10), 1158-1165, 2006 | 429 | 2006 |
| Prediction of MHC class I binding peptides, using SVMHC P Dönnes, A Elofsson BMC bioinformatics 3, 1-8, 2002 | 353 | 2002 |
| WIPI proteins: essential PtdIns3P effectors at the nascent autophagosome T Proikas-Cezanne, Z Takacs, P Dönnes, O Kohlbacher Journal of cell science 128 (2), 207-217, 2015 | 334 | 2015 |
| Predicting protein subcellular localization: past, present, and future P Dönnes, A Höglund Genomics, Proteomics and Bioinformatics 2 (4), 209-215, 2004 | 157 | 2004 |
| SherLoc: high-accuracy prediction of protein subcellular localization by integrating text and protein sequence data H Shatkay, A Höglund, S Brady, T Blum, P Dönnes, O Kohlbacher Bioinformatics 23 (11), 1410-1417, 2007 | 154 | 2007 |
| Machine learning techniques for personalised medicine approaches in immune-mediated chronic inflammatory diseases: applications and challenges J Peng, EC Jury, P Dönnes, C Ciurtin Frontiers in pharmacology 12, 720694, 2021 | 115 | 2021 |
| SVMHC: a server for prediction of MHC-binding peptides P Dönnes, O Kohlbacher Nucleic acids research 34 (suppl_2), W194-W197, 2006 | 108 | 2006 |
| Barrier properties and transcriptome expression in human iPSC-derived models of the blood–brain barrier L Delsing, P Dönnes, J Sánchez, M Clausen, D Voulgaris, A Falk, ... Stem cells 36 (12), 1816-1827, 2018 | 106 | 2018 |
| Integrated modeling of the major events in the MHC class I antigen processing pathway P Dönnes, O Kohlbacher Protein Science 14 (8), 2132-2140, 2005 | 100 | 2005 |
| Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines … Clinical & Experimental Immunology 181 (3), 385-400, 2015 | 82 | 2015 |
| Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: a European retrospective multicohort analysis J Quistrebert, S Hässler, D Bachelet, C Mbogning, A Musters, PP Tak, ... Seminars in Arthritis and Rheumatism 48 (6), 967-975, 2019 | 67 | 2019 |
| Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19 S Havervall, H Ng, A Jernbom Falk, N Greilert‐Norin, A Månberg, ... Journal of internal medicine 291 (1), 72-80, 2022 | 64 | 2022 |
| Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach GA Robinson, J Peng, P Dönnes, L Coelewij, M Naja, A Radziszewska, ... The Lancet Rheumatology 2 (8), e485-e496, 2020 | 63 | 2020 |
| A mathematical framework for the selection of an optimal set of peptides for epitope-based vaccines NC Toussaint, P Dönnes, O Kohlbacher PLoS computational biology 4 (12), e1000246, 2008 | 56 | 2008 |
| Plasma profiling reveals human fibulin-1 as candidate marker for renal impairment M Neiman, JJ Hedberg, PR Donnes, I Schuppe-Koistinen, S Hanschke, ... Journal of proteome research 10 (11), 4925-4934, 2011 | 51 | 2011 |
| Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium S Hässler, D Bachelet, J Duhaze, N Szely, A Gleizes, S Hacein-Bey Abina, ... PLoS medicine 17 (10), e1003348, 2020 | 47 | 2020 |
| Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay HS Schultz, SL Reedtz-Runge, BT Bäckström, K Lamberth, CR Pedersen, ... PLoS One 12 (5), e0178544, 2017 | 41 | 2017 |
| Occurrence of anti-drug antibodies against interferon-beta and natalizumab in multiple sclerosis: a collaborative cohort analysis D Bachelet, S Hässler, C Mbogning, J Link, M Ryner, R Ramanujam, ... PloS one 11 (11), e0162752, 2016 | 39 | 2016 |
| Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: a descriptive study of test results J Link, R Ramanujam, M Auer, M Ryner, S Hässler, D Bachelet, ... PLoS One 12 (2), e0170395, 2017 | 37 | 2017 |
| SNEP: SNP-derived epitope prediction program for minor H antigens MM Schuler, P Dönnes, MD Nastke, O Kohlbacher, HG Rammensee, ... Immunogenetics 57, 816-820, 2005 | 37 | 2005 |
Oliver KohlbacherProfessor for Applied Bioinformatics, University of Tübingen在 uni-tuebingen.de 的电子邮件经过验证
